In 2023 as many as 11 biosimilars to Humira are headed for the US market.
Tony Hagen
Advertisement
Articles by Tony Hagen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Trial Supports Risankizumab for Pediatric Psoriasis
2
Dermatology Times Monthly FDA and Pipeline Review: October 2026
3
Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year
4
Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients
5